Clinical Trials Directory

Trials / Completed

CompletedNCT03396029

Tailored Written Lifestyle Feedback in Colorectal Cancer Screening

A Randomized Trial of Tailored Written Lifestyle Feedback in Colorectal Cancer Screening

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
3,642 (actual)
Sponsor
Oslo University Hospital · Academic / Other
Sex
All
Age
50 Years – 74 Years
Healthy volunteers
Accepted

Summary

This randomized controlled trial aims to investigate the effect of an individually tailored lifestyle feedback letter and a leaflet on lifestyle in the context of sigmoidoscopy screening.

Detailed description

Cancer screening may be used as a teachable moment for healthy lifestyle behaviours. This study aims to investigate the effect of minimal, but individually tailored lifestyle advice and a standard leaflet on healthy lifestyle given at a colorectal cancer screening context on one-year changes in these behaviours in a population-based sample of men and women. Individuals invited to sigmoidoscopy screening in the piloting of Norwegian Bowel Cancer Screening are additionally invited to this lifestyle intervention study. Changes in lifestyle are measured by a brief lifestyle questionnaire administered at prescreening and after one year. The intervention to the intervention arms is given after completion of the prescreening lifestyle questionnaire.

Conditions

Interventions

TypeNameDescription
BEHAVIORALIndividually tailored lifestyle feedbackThe written, standardized individually tailored lifestyle feedback includes feedback on consumption of fruit, berries and vegetables and alcohol, physical activity, smoking and body mass index.
BEHAVIORALStandard leafletThe leaflet is The Norwegian Cancer Society's one-page information brochure on healthy lifestyle behaviours for low cancer risk, including non-smoking, healthy body weight, physical activity, diet, moderate alcohol consumption, moderate sun exposure etc.

Timeline

Start date
2014-11-01
Primary completion
2016-10-30
Completion
2018-10-31
First posted
2018-01-10
Last updated
2019-08-28

Source: ClinicalTrials.gov record NCT03396029. Inclusion in this directory is not an endorsement.